HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Speaker at Drug Delivery Events - Sergey Suchkov
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and systems biology-related processes specific to a particular patient (ignoring persons-at-risk). A new systems approach to [....] » Read More

Speaker at Pharma Conferences - Bruce Daugherty
Keynote Presentation (In-Person)
Bruce Daugherty, Tonix Pharmaceuticals, United States

TNX-102 SL is a sublingual formulation for cyclobenzaprine (CBP) hydrochloride (HCl) designed for bedtime dosing that is being developed for fibromyalgia (FM) via improvement in sleep quality. TNX-102 SL is a eutectic formulation of CBP and D-mannitol (see companion abstracts, Fo [....] » Read More

Speaker at Pharma Conferences - Marino Nebuloni
Keynote Presentation (In-Person)
Marino Nebuloni, University of Insubria, Italy

In solid drug product formulation, the knowledge of possible interactions between the drug substance and the excipients is a crucial point for the prediction of chemical and physical stability. Often, an excipient(s) can modify the biological activity and chemical stability of th [....] » Read More

Speaker at Pharma conferences - Priya Hays
Oral Presentation (In-Person)
Priya Hays, Hays Documentation Specialists, LLC, United States

Background: PARP inhibitors and CDK 4/6 inhibitors have been studied extensively as model targeted agents for advanced and metastatic breast cancer with hormone receptor positive/HER2 negative molecular subtype, the most common in the patient population. Both agents have been eva [....] » Read More

Speaker at Pharma Conferences - Stella Kafkala
Oral Presentation (In-Person)
Stella Kafkala, Genepharm Pharmaceutical Company, Greece

Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia (SAA). The molecule of eltrombopag acquires 6 protonatable site [....] » Read More

Speaker at Drug Delivery Events - Dasharath Muljibhai Patel
Oral Presentation (In-Person)
Dasharath Muljibhai Patel, Gujarat Technological University, India

Background: Conventional preparation of erythromycin ointment is available in the market as an ocular formulation. Ointment dosage form is linked to many side effects, including transient blurred vision, irritation and redness of the eye. Ointment dosage form also shows very low [....] » Read More

Speaker at Pharmaceutical Conference - Fatma Haddad
Oral Presentation (In-Person)
Fatma Haddad, University of Bradford, United Kingdom

Luteolin is a natural flavonoid abundant in several fruits, vegetables, and medicinal herbs. Although luteolin has numerous pharmacological activities, its low water solubility and bioavailability restrict its therapeutic efficacy. This work aims to overcome these limitations by [....] » Read More

Speaker at Pharma Conferences - Yusuke Shimoyama
Oral Presentation (In-Person)
Yusuke Shimoyama, Tokyo Institute of Technology, Japan

Pharmaceutical formulation techniques have been developed as achieving controlled-release system and high bioavailability of active pharmaceutical ingredients (APIs). Formation of the pharmaceutical suspension with nanoparticles or liposomes is one of the dosage forms to increase [....] » Read More

Speaker at Drug Delivery Events - Sergey Suchkov
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

A new systems approach to subclinical, predictive and/or diseased states and wellness resulted in a new Hi Tech trend in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, despite breakthroughs in designed-driven research that have led to an i [....] » Read More

Speaker at Drug Delivery Events - Shereen M Assaf
Oral Presentation (In-Person)
Shereen M Assaf, Jordan University of Science and Technology, Jordan

Benign prostatic hyperplasia (BPH), an enlargement of the prostate affecting older men, leads to urinary complications. Oral administration of Dutasteride (DTS) is a common treatment, but it poses challenges for the elderly, including difficulty in taking the medication by mouth, [....] » Read More

Speaker at Pharma conferences - Alper Onder
Oral Presentation (In-Person)
Alper Onder, Canakkale Onsekiz Mart University, Turkey

Bruton tyrosine kinase (BTK) is a downstream mediator of the B cell receptor (BCR) signalling pathway and affects B cell proliferation and differentiation. Evidence showing BTK expression in the majority of hematological cells has led to the hypothesis that BTK inhibitors such as [....] » Read More

Speaker at Pharma Conferences - Ferah Comert Onder
Oral Presentation (In-Person)
Ferah Comert Onder, Canakkale Onsekiz Mart University, Turkey

Triple-negative breast cancer (TNBC) is subtype of breast cancer is known for aggressive, leading to early relapses, metastasis and poor clinical prognosis. Significant heterogeneity and drug resistant phenotype and lack of effective targeted therapeutics contribute to poor patie [....] » Read More

Speaker at Drug Delivery Events - Shereen M Assaf
Oral Presentation (In-Person)
Shereen M Assaf, Jordan University of Science and Technology, Jordan

Levodopa, an essential precursor of dopamine, was widely used to address motor disorders in the early stages of Parkinson's disease. However, its effectiveness was hindered by a short plasma half-life, enzymatic conversion in the systemic circulation, limited absorption in th [....] » Read More

Speaker at Drug Delivery Events -  Andreas M Papas
Keynote Presentation (In-Person)
Andreas M Papas, Antares Health Products, United States

Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glyco [....] » Read More

Speaker at Pharmaceutical Conference - Thomas Ullrich
Keynote Presentation (In-Person)
Thomas Ullrich, Novartis Biomedical Research, Switzerland

Long-acting injectable (LAI) medications represent the combination of a powerful drug substance and an injectable drug formulation that guarantees that the affected tissue is consistently exposed to the active molecule for an extended therapeutic treatment period without elicitin [....] » Read More

Speaker at Drug Delivery Events - Miroslav Radenkovic
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Hypertension is a common condition characterized by persistently high blood pressure (140/90 mmHg or higher). Lowering high blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Regardless of outstanding result [....] » Read More

Speaker at Pharmaceutical Conference - Maria Cristina Gamberini
Keynote Presentation (In-Person)
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy

Most commonly produced and marketed drugs are formulated with the pharmacologically active ingredient in solid form (crystalline or amorphous). The solid form is carefully chosen for its characteristics, to increase the stability of the drug, facilitate its formulation, optimize [....] » Read More

Speaker at Pharmaceutical Conference - Thomas J. Webster
Keynote Presentation (In-Person)
Thomas J. Webster, Mansfield Bioincubator, United States

Today’s biomaterials are harming the environment and left unchanged, are predicted to continue to harm the environment in the decades ahead at an alarming rate. Whether through a large carbon footprint during manufacturing, catheter waste, or extensive polymeric cell cultur [....] » Read More

Speaker at Pharma Conferences - Rassa Pegahi
Oral Presentation (In-Person)
Rassa Pegahi, UPSA, France

Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use, debate exists regarding the analgesic mechanism of action (MoA) of paracetamol. A growing body of evidence [....] » Read More

Speaker at Pharmaceutical Conference - Fatemeh Ahmadvand
Oral Presentation (In-Person)
Fatemeh Ahmadvand, University of the Genova, Italy

Advances in genetic engineering vaccines have made DNA vaccines a highly promising option for hereditary and acquired illnesses. The main obstacle; nevertheless, is the absence of an ideal delivery system, which severely restricts DNA vaccines' capacity to generate an immune [....] » Read More

Speaker at Pharmaceutical Conference - Barbara De Filippis
Oral Presentation (In-Person)
Barbara De Filippis, University of Chieti, Italy

Hybrid compounds are artificial scaffolds made of two or more pharmacophores that are jointed or overlapped in a single chemical entity. The strategy of combining two different and independently acting compounds into one covalently linked hybrid compound aims to increase the phar [....] » Read More

Speaker at Drug Delivery Events - Alexander Valyaev
Oral Presentation (In-Person)
Alexander Valyaev, Nuclear Safety Institute of the Russian Academy of Sciences, Russian Federation

Using of nanotechnologies requires detailed analysis of existing obstacles to technology translation. Here we consider some bio nanotechnologies  for the treatment of human bones, including its musculoskeletal system, experiencing the maximum load during the functioning of a [....] » Read More

Speaker at Pharmaceutical Conference - Anders B Christensen
Oral Presentation (In-Person)
Anders B Christensen, Apillet, Denmark

Apillet has developed a unique Oral drug delivery concept (APIVault) which enable targeted release in the intestine of Sensitive (bio)pharmaceuticals, Probiotics and Nutraceuticals. Such compounds are prone to degradation in the stomach and must be protected by a gastro-resistant [....] » Read More

Speaker at Pharma Conferences - Ibrahim A Al Othaim
Oral Presentation (In-Person)
Ibrahim A Al Othaim, Saudi Food & Drug Authority, Saudi Arabia

Background: Enrofloxacin (enro) is a broad-spectrum fluoroquinolone antibiotic active against both Gram-positive and Gram-negative bacteria. It is used extensively in both animals and humans due to its high bioavailability and the wide range of susceptible infections. However the [....] » Read More

Speaker at Pharma Conferences - Siobhan Fogarty
Poster Presentation (In-Person)
Siobhan Fogarty, Tonix Pharma Limited, Ireland

The formulation of cyclobenzaprine HCl contained in TNX-102 SL has been designed specifically for sublingual administration. Earlier clinical studies indicated that the addition of a basifying agent was necessary for optimal transmucosal absorption. The TNX-102 SL formulation wit [....] » Read More

Speaker at Thomas J. Webster - Riyadh Al Asady
Poster Presentation (In-Person)
Riyadh Al Asady, University of Sheffield, United Kingdom

In a multi-processes pharmaceutical continuous tablet production line such as ConsiGmaTM -25, the quality of the final tablet is a function of different processes and formulation parameters of different units. The effect significance of each unit depends not only on the unit itse [....] » Read More

Speaker at Pharma conferences - Yuna Tatsumi
Poster Presentation (In-Person)
Yuna Tatsumi, Tokyo Institute of Technology, Japan

Pharmaceutical cocrystal is one of the crystal engineering techniques to improve the solubility and bioavailability of active pharmaceutical ingredients (APIs). Cocrystal is a crystal composed of API and other molecules called as coformer. There are many fabrication techniques fo [....] » Read More

Speaker at Drug Delivery Events - Savvopoulos Pantelis
Poster Presentation (In-Person)
Savvopoulos Pantelis, Genepharm Pharmaceutical Company, Greece

Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia (SAA). The molecule of eltrombopag acquires 6 protonatable sites a [....] » Read More

Speaker at Pharma Conferences - Rassa Pegahi
Poster Presentation (In-Person)
Rassa Pegahi, UPSA, France

Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use, debate exists regarding the analgesic Mechanism of Action (MoA) of paracetamol. A growing body of evidence [....] » Read More

Speaker at Drug Delivery Events - Shu Chun Liu
Poster Presentation (In-Person)
Shu Chun Liu, Show Chwan Memorial Hospital, Taiwan

Background: Senescence leads to permanent cell-cycle arrest and is a potential target for cancer therapy. Paeoniflorin (PAE) is a monoterpene isolated from Traditional Chinese Medicine (TCM) Paeonia Alba, which has been used as an anti-inflammatory drug in clinical practice wit [....] » Read More

Speaker at Pharmaceutical Conference - Mutaz S Salem
Poster Presentation (In-Person)
Mutaz S Salem, Jordan University of Science and Technology, Jordan

Conventional oral formulations are mainly absorbed in the small intestine. This limits their use in the treatment of some diseases associated with the colon, where the drug has to act topically at the inflammation site. This paved the way for the development of a smart colonic dr [....] » Read More

Speaker at Pharmaceutical Conference - Bernd Blobel
Keynote Presentation (Virtual)
Bernd Blobel, University of Regensburg, Germany

Health and social care systems around the globe currently undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), considering the individual health status, conditions, genetic and genomic dispositions, etc., in personal, soci [....] » Read More

Speaker at Pharma Conferences - Saad Tayyab
Keynote Presentation (Virtual)
Saad Tayyab, UCSI University, Malaysia

Using a variety of spectroscopic methods and in silico analysis, the binding interactions between three antimalarial medications, mefloquine (MEF), lumefantrine (LUM), and pyrimethamine (PYR) and the primary plasma transporter, human serum albumin (HSA) were examined. Molecular d [....] » Read More

Speaker at Drug Delivery Events - Delia Teresa Sponza
Keynote Presentation (Virtual)
Delia Teresa Sponza, Dokuz Eylul University, Turkey

Pharmaceuticals are highly persistent towards hydrolysis, adsorption, biodegradation, and abiotic degradation .As a result, such pharmaceutical compounds are not effectively removed during sewage treatment. Furthermore, sewage effluents and hospital effluents are important point [....] » Read More

Speaker at Pharmaceutical Conference - Consolato M Sergi
Keynote Presentation (Virtual)
Consolato M Sergi, University of Ottawa, Canada

Introduction: Metabolic-(non-alcoholic) associated fatty liver disease (MAFLD/NAFLD) has increasingly become a worldwide epidemic. It has been suggested that renaming NAFLD to MAFLD is critical in identifying patients with advanced fibrosis and poor cardiovascular outcomes. There [....] » Read More

Speaker at Pharmaceutical Conference - Axel H Schonthal
Keynote Presentation (Virtual)
Axel H Schonthal, University of Southern California, United States

Perillyl alcohol is a naturally occurring monoterpene related to limonene. We have synthesized a clinical-grade version, called NEO100 (NeOnc Technologies, Inc., Los Angeles, California), which has revealed a variety of highly promising characteristics that we are exploring towar [....] » Read More

Speaker at Pharma Conferences - Luis Jesus Villarreal Gomez
Keynote Presentation (Virtual)
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico

Wound dressings play a pivotal role in wound care by cleansing, shielding, and covering wounds, thereby influencing healing duration, cost-effectiveness, and patient comfort. Electrospun fibers emerge as a promising avenue in this field due to their diverse attributes, including [....] » Read More

Speaker at Pharmaceutical Conference - Madhav Bhatia
Keynote Presentation (Virtual)
Madhav Bhatia, University of Otago, New Zealand

Acute pancreatitis is a common clinical condition, for which there is no satisfactory treatment available at this time. Excessive systemic inflammatory response syndrome (SIRS) in acute pancreatitis leads to distant organ damage and multiple organ dysfunction syndrome (MODS), whi [....] » Read More

Speaker at Pharma Conferences - Bhupendra Gopalbhai Prajapati
Keynote Presentation (Virtual)
Bhupendra Gopalbhai Prajapati, Ganpat University, India

The present investigation is focused on the application of the Quality by Design (QbD) approach for the development and optimization of SLN formulation of Ivacaftor (IVF). IVF SLN was formulated with the help of homogenization and ultrasonication methods by incorporating Labrasol [....] » Read More

Speaker at Pharma Conferences - John K Maesaka
Keynote Presentation (Virtual)
John K Maesaka, NYU Long Island School of Medicine, United States

Background: The approach to hyponatremia is in a state of flux. Cerebral/renal salt wasting (RSW) is considered rare and presents with identical parameters as SIADH that create a diagnostic and therapeutic dilemma, whether to fluid-restrict water-logged patients with SIADH or adm [....] » Read More

Speaker at Pharma Conferences - Elisabetta Stretti
Oral Presentation (Virtual)
Elisabetta Stretti, University of Patras, Greece

Drug-coated balloon (DCB) treatment has recently emerged as an effective non-stent-based strategy for the treatment of atherosclerotic arteries in peripheral artery disease (PAD). DCBs are designed to dilate into the stenotic lesions while delivering antiproliferative drugs to lo [....] » Read More

Speaker at Drug Delivery Events - Raja Chakraverty
Oral Presentation (Virtual)
Raja Chakraverty, Indian Council of Medical Research, India

The study was conducted to gather information to assess the extent of impact of antimicrobial stewardship (AMSP) practices on antimicrobial prescribing patterns and bacterial resistance profiles among indoor patients across ten ICU and non-ICU departments at the Institute of Post [....] » Read More

Speaker at Drug Delivery Events - Pratip kashinath chaskar
Oral Presentation (Virtual)
Pratip kashinath chaskar, D Y Patil University School of Pharmacy Navi Mumbai, India

The forthcoming presentation will delve into the fundamental tenets of Green Chemistry, highlighting key methodologies such as Phase Transfer Catalysis (PTC), Ionic Liquids (IL), Sonochemistry, and Microwave Irradiation (MWI). These cutting-edge approaches epitomize the evolution [....] » Read More

Speaker at Pharmaceutical Conference - Ayse Nur Oktay
Oral Presentation (Virtual)
Ayse Nur Oktay, University of Health Sciences-Gulhane Faculty of Pharmacy, Turkey

In vitro drug dissolution is a laboratory test of drug tablets to assess product quality. The test measures drug release (i.e. drug dissolution) from tablets. There are numerous scenarios during drug development, as well in post-market life-cycle management, when there are manufa [....] » Read More

Speaker at Drug Delivery Events - Natassa Pippa
Oral Presentation (Virtual)
Natassa Pippa, University of Athens, Greece

Controlled-release drug delivery systems exhibit a gamut of benefits, including improved therapeutic efficacy, reduced side effects, improved patient compliance, and optimized medicine use. For this reason, there is versatility in drug formulation for controlled release purposes. [....] » Read More

Speaker at Pharma Conferences - Muhammed Tilahun Muhammed
Oral Presentation (Virtual)
Muhammed Tilahun Muhammed, Suleyman Demirel University, Turkey

Target/Structure-based drug design needs the presence of the target structure to move forward in the drug discovery process. However, the number of macromolecule structures available in the available data banks is limited relative to the high macromolecule sequence release. Homol [....] » Read More

Speaker at Pharmaceutical Conference - Panagiotis Mallis
Oral Presentation (Virtual)
Panagiotis Mallis, Biomedical Research Foundation Academy of Athens, Greece

Background: Mesenchymal Stromal Cells (MSCs), a multipotent stem cell population which can efficiently be obtained from different tissue sources, exert key specific regenerative and immunomodulatory properties. However, MSCs require priming through binding of IFN-γ to the r [....] » Read More

Speaker at Pharmaceutical Conference - Rama Rao Nadendla
Oral Presentation (Virtual)
Rama Rao Nadendla, Chalapathi Institute of Pharmaceutical Sciences, India

The present study aimed to formulate rivaroxaban nanosuspension by nanoprecipitation with the ultrasonication method and was stabilized by different concentrations of Fenugreek Seed Mucilage, Microcrystalline Cellulose and Carboxymethyl Cellulose. The formulated nanosuspensions w [....] » Read More

Speaker at Pharmaceutical Conference - Asish Bhaumik
Oral Presentation (Virtual)
Asish Bhaumik, School of Pharmaceutical Science, India

Introdution: 1, 3, 4-oxadiazole is a five membered heterocyclic aromatic compound containing two nitrogen atom at position three and four and one oxygen atom present at position one. 1, 3, 4 oxadiazole is thermally stable than other oxadiazoles, these oxadiazole are very&nbs [....] » Read More

Speaker at Pharmaceutical Conference - Dharmendra Kumar
Oral Presentation (Virtual)
Dharmendra Kumar, Sanskaram University, India

In recent years, various types of natural polymers have gained prominence in drug delivery systems due to their biocompatibility, biodegradability, and ease of modification. Recent research has further enhanced the capabilities of these polymers, expanding their functions in drug [....] » Read More

Speaker at Pharma Conferences - Deepika Sharma
Oral Presentation (Virtual)
Deepika Sharma, CGC Mohali Punjab, India

Among the fungal genera, members of the genus Candida are most common causal organisms of human infections. In recent years, increasing drug resistance in fungal pathogenic strains specifically, clinical strains require immediate attention to develop alternative antifungal agents [....] » Read More

Speaker at Pharmaceutical Conference - Rayhan Shahid Shanavas
Oral Presentation (Virtual)
Rayhan Shahid Shanavas, Oakridge International School, India

Infectious diseases especially associated with multidrug resistant pathogens in critically ill patients is an area of global research and concern for healthcare professionals across both private and public sector. Sulbactam and Durlobactam have been approved as a combination drug [....] » Read More

Speaker at Pharmaceutical Conference - Maria Borrell
Oral Presentation (Virtual)
Maria Borrell, Sant Pau Research Institute, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Speaker at Pharmaceutical Conference - Merita Kucuku
Oral Presentation (Virtual)
Merita Kucuku, Freelance consultant, Albania

Human Papillomavirus (HPV) vaccines are vaccines used for vaccination against human papillomavirus infection. HPV vaccines prevent infection from different types of human papillomavirus which cause risk for cervical cancer. Vaccination with different types of HPV has an impact [....] » Read More

Speaker at Pharmaceutical Conference - Shripriya Kalbhavi
Oral Presentation (Virtual)
Shripriya Kalbhavi, Lynbrook High School, United States

Despite the widespread use of hypodermic needles in intradermal medication delivery, they remain a source of pain and trauma in patients young and old. The research introduces a novel approach to active medication delivery using microneedle arrays, utilizing the high swellability [....] » Read More

Speaker at Pharma Conferences - Anna Weronika Sobanska
Oral Presentation (Virtual)
Anna Weronika Sobanska, Medical University of Lodz, Poland

Pregnant women are exposed to a variety of environmental pollutants – pesticides, drugs, substances of abuse or cosmetic raw materials that enter the body of a mother-to-be by a variety of routes - oral (with contaminated food or water), through skin or mucous membranes or [....] » Read More

Speaker at Pharmaceutical Conference - Vyacheslav R. Shulunov
Oral Presentation (Virtual)
Vyacheslav R. Shulunov, Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Science, Russian Federation

The calculated specifications of Roll Porous Scaffold (RPS) are orders of magnitude superior to all currently dominant 3D bioprinters in speed, volume, and print density without the use of expensive equipment and components: print density of 10−15 µm cells u [....] » Read More

Speaker at Pharmaceutical Conference - Asit Kumar Chakraborty
Oral Presentation (Virtual)
Asit Kumar Chakraborty, Vidyasagar University, India

MDR-bacteria causes sepsis and death in patients due to their power to inactivate antibiotics like ampicillin, cefotaxime, tetracycline, streptomycin, chloramphenicol, erythromycin and ciprofloxacin. The mdr genes (amp, blaCTX-M, blaNDM1, cat, aac2’/3’/6’, strAB [....] » Read More

Speaker at Pharma Conferences - Preeti Sharma
Oral Presentation (Virtual)
Preeti Sharma, Autonomous State Government Medical College, India

Introduction: Preeclampsia(PE) is pregnancy related syndrome which is mainly by gestational hypertension with proteinuria. it affects 2 to 10 % of pregnant women. Improper maternal spiral artery remodelling leads to decreased perfusion to the placenta. Hypoxic placental orga [....] » Read More

Speaker at Drug Delivery Events - Khagga Bhavyasri
Oral Presentation (Virtual)
Khagga Bhavyasri, Osmania University, India

To develop and validate a simple and sensitive UV spectrophotometric method for Quantification of Hesperidin in bulk and Ayurveda formulation including plant extracts using chromogenic compound Gibb’s reagent (2, 6-Dichloro quinone 4-Chloroimide). Chromogenic method was dev [....] » Read More

Speaker at Pharmaceutical Conference - Rudra Pratap Singh Rajput
Oral Presentation (Virtual)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India

Background: Lawsonia inermis L. (Lawsone) was reported to contain carbohydrates, proteins, flavonoids and phenolic compounds, alkaloids, terpenoids. The plant has also been reported to have hepatoprotective, anti-inflammatory, antiviral, antifungal and anticancer properties. Laws [....] » Read More

Speaker at Pharma Conferences - Abhay Tharmatt
Oral Presentation (Virtual)
Abhay Tharmatt, BITS Pilani, India

Psoriasis, an incurable chronic inflammatory skin disease, is characterised by enhanced angiogenesis, abnormal keratinocyte differentiation, and immune cell invasion. Angiogenesis, a critical factor in endothelial cell proliferation, adhesion, and migration, is driven by the ov [....] » Read More

Speaker at Drug Delivery Events -  Ali Yetgin
Oral Presentation (Virtual)
Ali Yetgin, Institute of Nature and Applied Sciences, Department of Biotechnology, Adana, Turkey, Turkey

Medicinal plants have been fundamental in both traditional and modern medicine, offering a wide array of bioactive compounds crucial for therapeutic purposes. The escalating impact of climate change presents notable risks to the accessibility and effectiveness of these essential [....] » Read More

Speaker at Pharma Conferences - Suresh P.K
Oral Presentation (Virtual)
Suresh P.K, VIT University, India

Extracts from plant sources have been mined for their anti-cancer potential. The n-butanolic extract of the leaves of A.muricata exhibited a higher cytotoxic potential in MDA-MB-435s & HaCaT cells in comparison with normal hepatic cells. The free radical scavenging potential [....] » Read More

Speaker at Pharmaceutical Conference - Neha Agarwal
Oral Presentation (Virtual)
Neha Agarwal, University of Lucknow, India

Pharmaceuticals are essential to ensure the high standards of human health and wellbeing. Extensive and uncontrolled usage under different classes such as antibiotics, analgesics, antipyretics, antidepressant, anticonvulsants, beta-blockers, and steroids, etc. pose high environme [....] » Read More

Speaker at Pharma Conferences - Gurpreet Singh
Oral Presentation (Virtual)
Gurpreet Singh, IQVIA, United Kingdom

The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical Companies based on projected R&D spending in 2026 are Roche, Johnson & Johnson, Merck [....] » Read More

Speaker at Pharmaceutical Conference - Tarek Aboul Fadl
Oral Presentation (Virtual)
Tarek Aboul Fadl, Assiut University, Egypt

Cancer remains a global health threat despite advances in research and technology. According to International Agency for Research on Cancer, the cancer burden will increase by about 77% by 2050, further straining health systems, people and communities. Although cancer chemotherap [....] » Read More

Speaker at Drug Delivery Events - Teresa Carvajal
Oral Presentation (Virtual)
Teresa Carvajal, Purdue University, United States

Surface and physico-chemical properties are critical in formulation and in processes involving the handling, processing, packaging, shelf-life and bioavailability of medicines. In this presentation, we will explore and discuss the intricate ways in which interactions at the surfa [....] » Read More

Speaker at Drug Delivery Events - Andre Luiz Pereira
Oral Presentation (Virtual)
Andre Luiz Pereira, Hemominas Foundation, Brazil

The overprescription of pharmaceuticals, a phenomenon known as medicationalization, has led to unintended environmental consequences, contributing to the rising issue of pharmacopollution. This article explores the intricate relationship between medicationalization and pharmacopo [....] » Read More

Speaker at Drug Delivery Events - Ruchika Bajaj
Oral Presentation (Virtual)
Ruchika Bajaj, University of California San Francisco, United States

Membrane proteins constitute 30% of the genome in organisms and are involved in numerous physiological processes. ABC transporters is a class of membrane proteins which are ubiquitously present in all organisms, bind and hydrolyze ATP to power the solute transport and are associa [....] » Read More

Speaker at Pharma conferences - Afonin S.M
Poster Presentation (Virtual)
Afonin S.M, National Research University of Electronic Technology, Russian Federation

An electro magneto elastic actuator is electro magneto mechanical device intended for actuation of mechanisms, systems based on the piezoelectric, electrostriction, piezomagnetic, magnetostriction effects, converts electric or magnetic signals into mechanical movement and force. [....] » Read More

Speaker at Drug Delivery Events - Yuxin Liu
Poster Presentation (Virtual)
Yuxin Liu, chongqing university three gorges hospital, China

Objective: The surge in incidents of acute poisoning from pharmaceuticals and chemicals necessitates the exploration of effective and safe treatment alternatives. This review aims to evaluate the efficacy, underlying mechanisms, and safety profiles of plant-based detoxifying agen [....] » Read More

Watsapp